김진국 교수
Jin‐Kuk Kim
한양대학교 화학공학과 · 공학
연구실 소개
김진국 교수의 연구실은 유전적 질환의 정밀 진단과 맞춤형 치료제 개발을 핵심으로 삼고 있습니다. 특히 스플라이스 조절 항체단핵산(ASO) 기반의 'N-of-1' 치료 전략을 통해 희귀 신경퇴행성 질환 환자에게 맞춤 약물(milasen)을 개발한 바 있으며, 이는 유전적 변이를 기반으로 한 정밀의료의 새로운 모델을 제시합니다. 또한 냉각수 시스템 최적화, 혼합 냉매 사이클 설계, 탄소 포집 공정의 초구조 최적화 등 에너지 효율성과 환경 공학 분야의 혁신적 설계 기법을 동시에 개발하고 있습니다. 이처럼 의료와 공정 공학의 융합적 접근을 통해 실질적인 환자 치료와 산업적 지속가능성을 동시에 추구하고 있습니다.
연구 현황
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
주요 논문
15Genome sequencing is often pivotal in the diagnosis of rare diseases, but many of these conditions lack specific treatments. We describe how molecular diagnosis of a rare, fatal neurodegenerative condition led to the rational design, testing, and manufacture of milasen, a splice-modulating antisense oligonucleotide drug tailored to a particular patient. Proof-of-concept experiments in cell lines from the patient served as the basis for launching an "N-of-1" study of milasen within 1 year after f
A new approach for the optimal design of mixed refrigerant cycles is presented. It is based on mathematical programming and offers significant improvements in relation to previous approaches. It includes multistage refrigerant compression, full enforcement of the minimum temperature difference in heat exchangers, simultaneous optimization of variables, consideration of capital costs, and the use of stochastic optimization (genetic algorithm) to overcome local optima. The approach can be applied
Abstract Splice-switching antisense oligonucleotides (ASOs) could be used to treat a subset of individuals with genetic diseases 1 , but the systematic identification of such individuals remains a challenge. Here we performed whole-genome sequencing analyses to characterize genetic variation in 235 individuals (from 209 families) with ataxia-telangiectasia, a severely debilitating and life-threatening recessive genetic disorder 2,3 , yielding a complete molecular diagnosis in almost all individu
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor, yet with no targeted therapy with substantial survival benefit. Recent studies on solid tumors showed that fusion genes often play driver roles and are promising targets for pharmaceutical intervention. To survey potential fusion genes in GBMs, we analysed RNA-Seq data from 162 GBM patients available through The Cancer Genome Atlas (TCGA), and found that 3' exons of neurotrophic tyrosine kinase receptor type 1 (NTRK1, enco
Abstract An automated approach from the systematic investigation of interactions between cooling‐tower performance and the cooling‐water network design was developed for retrofit design of cooling‐water systems. Introducing reuse of cooling water between different cooling duties enables cooling systems to be debottlenecked. The series arrangement of heat exchangers, however, results in a pressure drop increase because of the cooling water reuse. An optimization model for cooling‐water networks d
대표 연구 분야
김진국 교수의 연구를 Nubint에서 더 깊이 살펴보세요
이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.